Common side-effects of BTK inhibitors (ibrutinib and acalabrutinib) in the treatment of CLL
Where will leukemia research go next?
How to treat elderly CLL patients in the light of novel therapies
An update on kinase inhibitors from EHA 2017
Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax